World India: Nestlé violated law conducting clinical trials for breast milk substitute on premature babies

Discussion in 'Headline News' started by tom_mai78101, Aug 3, 2019.

  1. tom_mai78101

    tom_mai78101 The Helper Connoisseur / Ex-MineCraft Host Staff Member

    Ratings:
    +966 / 4 / -1
    A prominent manufacturer of infant milk substitute is now under the Union Health Ministry’s scanner for sponsoring a research titled “Multicentric Observational Study to Observe Growth in Preterm hospitalised infants” in alleged violation of rules in five hospitals across the country.

    The manufacturer, Nestle India Ltd., conducted clinical trials on 75 premature babies in five hospitals on substitutes for breast milk in complete contravention of the The Infant Milk Substitutes, Feeding Bottles, and Infant Foods (Regulation Of Production, Supply And Distribution) Act 1992 And Amendment Act 2003( IMS Act).

    The alleged violation was found by the Breastfeeding Promotion Network of India (BPNI) on screening the trial registry of the Indian Council of Medical Research (ICMR).

    The BPNI complained to Union Health Minister Harsh Vardhan on July 17 alleging that the company had violated Section 9(2) of the IMS Act.

    This Section states that no producer, supplier or distributor shall offer or give any contribution or pecuniary benefit to a health worker or any association of health workers, including funding of seminar, meeting, conferences, educational course, contest, fellowship, research work or sponsorship.


    Read more here. (The Hindu)
     

Share This Page